Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 147

Related Articles by Review for PubMed (Select 17597103)

1.

Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model.

Whitehurst B, Flister MJ, Bagaitkar J, Volk L, Bivens CM, Pickett B, Castro-Rivera E, Brekken RA, Gerard RD, Ran S.

Int J Cancer. 2007 Nov 15;121(10):2181-91.

PMID:
17597103
2.

Molecular control of lymphatic metastasis.

Achen MG, Stacker SA.

Ann N Y Acad Sci. 2008;1131:225-34. doi: 10.1196/annals.1413.020. Review.

PMID:
18519975
3.

Lymphangiogenic growth factors, receptors and therapies.

Lohela M, Saaristo A, Veikkola T, Alitalo K.

Thromb Haemost. 2003 Aug;90(2):167-84. Review.

PMID:
12888864
4.

The role of the VEGF-C/VEGFR-3 axis in cancer progression.

Su JL, Yen CJ, Chen PS, Chuang SE, Hong CC, Kuo IH, Chen HY, Hung MC, Kuo ML.

Br J Cancer. 2007 Feb 26;96(4):541-5. Epub 2006 Dec 12. Review.

5.

Molecular targeting of lymphatics for therapy.

Stacker SA, Hughes RA, Achen MG.

Curr Pharm Des. 2004;10(1):65-74. Review.

PMID:
14754406
6.
7.

Tumor-induced lymphangiogenesis: a target for cancer therapy?

Thiele W, Sleeman JP.

J Biotechnol. 2006 Jun 25;124(1):224-41. Epub 2006 Feb 23. Review.

PMID:
16497404
8.

Tumor-derived lymphangiogenic factors and lymphatic metastasis.

Cao Y, Zhong W.

Biomed Pharmacother. 2007 Oct;61(9):534-9. Epub 2007 Sep 14. Review.

PMID:
17904785
9.

How do angiopoietins Tie in with vascular endothelial growth factors?

Saharinen P, Bry M, Alitalo K.

Curr Opin Hematol. 2010 May;17(3):198-205. doi: 10.1097/MOH.0b013e3283386673. Review.

PMID:
20375888
10.

Pathways targeting tumor lymphangiogenesis.

Wissmann C, Detmar M.

Clin Cancer Res. 2006 Dec 1;12(23):6865-8. Review.

11.

Role of lymphangiogenic factors in tumor metastasis.

He Y, Karpanen T, Alitalo K.

Biochim Biophys Acta. 2004 Mar 4;1654(1):3-12. Review.

PMID:
14984763
12.

Molecular mechanisms of lymphangiogenesis.

Takahashi M, Yoshimoto T, Kubo H.

Int J Hematol. 2004 Jul;80(1):29-34. Review.

PMID:
15293565
13.

[Characterization of markers and growth factors for lymphatic endothelium].

Waś H.

Postepy Biochem. 2005;51(2):209-14. Review. Polish.

PMID:
16209358
14.

Tumor lymphangiogenesis and melanoma metastasis.

Rinderknecht M, Detmar M.

J Cell Physiol. 2008 Aug;216(2):347-54. doi: 10.1002/jcp.21494. Review.

PMID:
18481261
15.

Role of lymphangiogenesis in lung cancer.

Weryńska B, Dziegiel P, Jankowska R.

Folia Histochem Cytobiol. 2009 Jan;47(3):333-42. doi: 10.2478/v10042-009-0090-3. Review.

16.

VEGFs and receptors involved in angiogenesis versus lymphangiogenesis.

Lohela M, Bry M, Tammela T, Alitalo K.

Curr Opin Cell Biol. 2009 Apr;21(2):154-65. doi: 10.1016/j.ceb.2008.12.012. Epub 2009 Feb 21. Review.

PMID:
19230644
17.

Lymphangiogenesis, inflammation and metastasis.

Schoppmann SF.

Anticancer Res. 2005 Nov-Dec;25(6C):4503-11. Review.

18.
19.

Tumor and lymph node lymphangiogenesis--impact on cancer metastasis.

Tobler NE, Detmar M.

J Leukoc Biol. 2006 Oct;80(4):691-6. Epub 2006 Jun 22. Review.

20.

VEGF-VEGF receptor complexes as markers of tumor vascular endothelium.

Brekken RA, Thorpe PE.

J Control Release. 2001 Jul 6;74(1-3):173-81. Review.

PMID:
11489493
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk